Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001.

Source:http://linkedlifedata.com/resource/pubmed/id/19240643

Download in:

View as

General Info

PMID
19240643